Literature DB >> 7908873

Glucocorticoids regulate somatostatin peptide and steady state messenger ribonucleic acid levels in normal rat tissues and in a somatostatin-producing islet tumor cell line (1027B2).

D N Papachristou1, J L Liu, Y C Patel.   

Abstract

Although a number of previous studies have suggested that glucocorticoids influence somatostatin (SS) function at the peptide level in some tissues and SS mRNA levels in thyroid tumor cells, there has been no systematic investigation of the effects of glucocorticoids on SS gene expression in normal tissues. In the present study, we have examined the effect of dexamethasone (DEX) on SS secretion and gene expression in rat tissues using as models DEX-treated rats in vivo, primary cultures of rat islet and cerebrocortical cells, and a SS-producing rat islet tumor cell line (1027B2). In vivo DEX administration (0.5 mg/kg) for 3 or 8 days augmented SS-mRNA 2- to 3-fold in peripheral tissues (stomach, pancreas, and jejunum), but reduced it by 50-60% in brain. The DEX effect was time dependent, being more pronounced after 8 days than after 3 days of treatment. In all tissues, SS mRNA levels returned to control values 2 weeks after cessation of DEX. Changes in tissue content of immunoreactive SS paralleled those in SS mRNA. In cultured rat islet cells, 18-h incubation with DEX induced dose-dependent biphasic effects on immunoreactive SS and SS mRNA; low doses (10(-10) M) were stimulatory, and high doses (10(-8)-10(-5) M) were inhibitory. Insulin secretion displayed dose-dependent stimulation by DEX, whereas glucagon release was inhibited. The effect of DEX on SS mRNA levels in primary cultures of brain cells was solely inhibitory. 1027B2 cells responded to DEX with augmented immunoreactive SS secretion and SS mRNA levels at low concentration (10(-10) M), followed by a dose-dependent inhibition of both parameters with increasing DEX concentrations. We conclude that glucocorticoids exert significant effects on SS peptide production and steady state mRNA levels in normal SS-producing tissues in vivo, in vitro, and in cultured 1027B2 cells. The glucocorticoid effect is time and dose dependent, tissue specific, and at least in part due to a direct action of the steroid hormone on SS-producing cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7908873     DOI: 10.1210/endo.134.5.7908873

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  5 in total

1.  Evidence from immunoneutralization and antisense studies that the inhibitory actions of glucocorticoids on growth hormone release in vitro require annexin 1 (lipocortin 1).

Authors:  A D Taylor; H C Christian; J F Morris; R J Flower; J C Buckingham
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

2.  Optimization and evaluation of fluorescence in situ hybridization chain reaction in cleared fresh-frozen brain tissues.

Authors:  Vivek Kumar; David M Krolewski; Elaine K Hebda-Bauer; Aram Parsegian; Brian Martin; Matthew Foltz; Huda Akil; Stanley J Watson
Journal:  Brain Struct Funct       Date:  2021-01-02       Impact factor: 3.270

3.  Rapid and opposite effects of dexamethasone on in vivo and in vitro hypothalamic somatostatin release.

Authors:  C Estupina; J Belmar; L Tapia-Arancibia; H Astier; S Arancibia
Journal:  Exp Brain Res       Date:  1997-02       Impact factor: 1.972

4.  Opposing influences of glucocorticoids and interleukin-1beta on the secretion of growth hormone and ACTH in the rat in vivo: role of hypothalamic annexin 1.

Authors:  J G Philip; C D John; P O Cover; J F Morris; H C Christian; R J Flower; J C Buckingham
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

5.  Glucocorticoids activate somatostatin gene transcription through co-operative interaction with the cyclic AMP signalling pathway.

Authors:  J L Liu; D N Papachristou; Y C Patel
Journal:  Biochem J       Date:  1994-08-01       Impact factor: 3.857

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.